Lv7
3490 积分 2022-04-14 加入
18F-FDG PET/CT for predicting prognosis of B-cell non-Hodgkin lymphoma patients treated with chimeric antigen receptor T cells: the value of pre-infusion and M1 image
1个月前
已完结
Pre-infusion 18F-FDG PET/CT for Prognostic and Toxicity Prediction in B-cell Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-cell Therapy
1个月前
已完结
Baseline [18F]FDG PET features are associated with survival and toxicity in patients treated with CAR T cells for large B cell lymphoma
1个月前
已完结
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
1个月前
已完结
Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy
1个月前
已完结
[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies
1个月前
已完结
Post‐CAR T‐Cell Therapy Failure Metabolic Parameters Predict Survival and Response in Large B‐Cell Lymphoma
1个月前
已完结
Prognostic Value of [18F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis
1个月前
已关闭
Prognostic Value of [18F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis
1个月前
已关闭
Body composition quantified by CT: chemotherapy toxicity and prognosis in patients with diffuse large B-cell lymphoma
2个月前
已完结
皖公网安备34019202002308
